Small cell lung cancer: Clinical practice guidelines in oncology Journal Article


Authors: Kalemkerian, G. P.; Akerley, W.; Bogner, P.; Borghaei, H.; Chow, L. Q.; Downey, R. J.; Gandhi, L.; Ganti, A. K. P.; Govindan, R.; Grecula, J. C.; Hayman, J.; Heist, R. S.; Horn, L.; Jahan, T.; Koczywas, M.; Loo, B. W. Jr; Merritt, R. E.; Moran, C. A.; Niell, H. B.; O'Malley, J.; Patel, J. D.; Ready, N.; Rudin, C. M.; Williams, C. C. Jr; Gregory, K.; Hughes, M.
Article Title: Small cell lung cancer: Clinical practice guidelines in oncology
Abstract: Neuroendocrine tumors account for approximately 20% of lung cancers; most (≈15%) are small cell lung cancer (SCLC). These NCCN Clinical Practice Guidelines in Oncology for SCLC focus on extensive-stage SCLC because it occurs more frequently than limited-stage disease. SCLC is highly sensitive to initial therapy; however, most patients eventually die of recurrent disease. In patients with extensive-stage disease, chemotherapy alone can palliate symptoms and prolong survival in most patients; however, long-term survival is rare. Most cases of SCLC are attributable to cigarette smoking; therefore, smoking cessation should be strongly promoted. Copyright © 2013, JNCCN-Journal of the National Comprehensive Cancer Network.
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 11
Issue: 1
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2013-01-01
Start Page: 78
End Page: 98
Language: English
PROVIDER: scopus
PUBMED: 23307984
PMCID: PMC3715060
DOI/URL:
Notes: --- - "Cited By (since 1996): 1" - "Export Date: 1 April 2013" - "Source: Scopus"
Citation Impact
MSK Authors
  1. Robert J Downey
    254 Downey